HealthHIV prevention drug could cut global cases, but USAID cuts threaten access, experts say

Experts at the Aids 2026 Conference in Rio de Janeiro say new HIV prevention tools could sharply reduce infections worldwide. They highlighted lenacapavir, an injectable form of PrEP that requires only two doses each year. The World Health Organization recommended a year ago that governments make wider access to the drug a priority. But funding for HIV prevention has fallen dramatically across the world. Experts warn that cuts to US foreign aid through USAID could leave the people most in need unable to obtain the medication.

HIV preventionlenacapavirUSAIDglobal health

TThe Guardian★★★★☆2026-07-31 16:29Original